PCAT6 is actively involved in the pathogenesis of several other cancer types, including prostate cancer[10]; it is overexpressed in almost all types of tumor tissues, and Kaplan-Meier analysis of various tumors revealed that PCAT6 overexpression is weakly correlated with patient survival. This evidence concerns the gene PCAT6 and prostate carcinoma.